26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

IX. Selected Neuromuscular Disorders <strong>of</strong> <strong>Domestic</strong> <strong>Animals</strong><br />

477<br />

<strong>of</strong> muscle in which there is a marked increase in serum<br />

CK and AST enzyme activities, gross hypertrophy <strong>of</strong> some<br />

muscle groups, and weakness and atrophy <strong>of</strong> other muscles<br />

in dogs and cats. Affected individuals may also have a cardiomyopathy,<br />

as the dystrophin deficiency also involves<br />

cardiac my<strong>of</strong>ibers ( Moise et al. , 1991 ). In dogs, the onset<br />

<strong>of</strong> clinical signs is usually evident by 2 to 4 months <strong>of</strong> age<br />

and somewhat later in cats. In dogs, this disorder was first<br />

observed in golden retrievers and has subsequently been<br />

identified in other breeds, including Irish terriers, rottweilers,<br />

German short-haired pointers, and Samoyeds.<br />

Histological sections reveal focal lesions consisting <strong>of</strong><br />

my<strong>of</strong>iber clusters undergoing the spectrum <strong>of</strong> change from<br />

myonecrosis through macrophage infiltration and phagocytosis<br />

to regeneration. Individual fibers may be atrophic or<br />

hypertrophic, calcified, and hypercontracted, and may possess<br />

central nuclei. Beyond clinical signs and biopsy features,<br />

immunoblotting and immunocytochemical staining<br />

for dystrophin within muscle biopsies and genetic screening<br />

are valuable diagnostic methods for detecting dystrophin<br />

deficiency.<br />

C . Immune-Mediated Canine Masticatory<br />

Muscle Myositis<br />

The muscles <strong>of</strong> mastication are selectively affected in an<br />

inflammatory muscle disorder in dogs known as masticatory<br />

muscle myositis ( Evans et al. , 2004 ). Limb muscles are<br />

essentially spared. The muscles <strong>of</strong> mastication in the dog<br />

are principally composed <strong>of</strong> type 2 m my<strong>of</strong>ibers, fast-twitch<br />

fibers that possess a unique is<strong>of</strong>orm <strong>of</strong> myosin, heavy and<br />

light chains ( Shelton et al. , 1985 ). This disorder appears to<br />

be an MHC-1-restricted CD8( ) T-cell-mediated autoimmune<br />

disease ( Shelton and Paciello, 2006 ). Dogs afflicted<br />

with this disorder produce autoantibodies directed against<br />

type 2 m fibers LC2-M (myosin light chain 2-masticatory),<br />

which has little cross-reaction with type 2a fibers <strong>of</strong> limb<br />

muscles. Diagnosis <strong>of</strong> the disorder includes muscle biopsy<br />

demonstration <strong>of</strong> lymphocytic and plasmocytic cellular infiltrates<br />

around muscle fibers and in perivascular locations.<br />

Occasionally eosinophils are present as the predominant<br />

infiltrate. In chronic cases, muscle atrophy and fibrosis are<br />

apparent. Localization <strong>of</strong> immunoglobulins fixed to type 2 m<br />

fibers within the biopsy and demonstration <strong>of</strong> circulating<br />

antibodies against type 2 m fibers employing SPA-HRP are<br />

more specific diagnostic tests ( Shelton et al. , 1987 ).<br />

D . Disorders <strong>of</strong> Glyco(geno)lysis Affecting<br />

Skeletal Muscle<br />

Disorders <strong>of</strong> glyco(geno)lysis affecting skeletal muscles<br />

variably involve some excess storage <strong>of</strong> glycogen within<br />

affected my<strong>of</strong>ibers, resulting in the presence <strong>of</strong> glycogencontaining<br />

vacuoles. In humans, glycogen storage diseases<br />

(GSD) affecting muscle include deficiencies <strong>of</strong> α-l, 4-<br />

glucosidase (GSD-II), debranching enzyme (GSD-III),<br />

branching enzyme (GSD-IV), myophosphorylase (GSD-V),<br />

phosph<strong>of</strong>ructokinase (GSDVII), phosphorylase b kinase<br />

(VIII), phosphoglycerate kinase (GSD-IX), phosphoglycerate<br />

mutase (GSD-X), and lactate dehydrogenase (XI)<br />

( Tsujino et al. , 2000 ). Though variably documented, some<br />

<strong>of</strong> these disorders also occur in domestic animals.<br />

1 . α -1,4-Glucosidase Defi ciency (GSD II)<br />

Lysosomal α -1,4-glucosidase deficiency, also known as<br />

Pompe’s disease, generalized type II glycogenosis, and acid<br />

maltase deficiency, occurs in humans with childhood (infantile<br />

and juvenile) and adult forms, which are variations <strong>of</strong><br />

the same disorder based on the age <strong>of</strong> onset and tissue and<br />

organ involvement ( Reuser et al. , 1995 ). This disorder is<br />

inherited as an autosomal recessive trait. This disorder has<br />

also been reported in shorthorn and Brahman cattle ( Dennis<br />

et al. , 2000 ). Both infantile and late-onset equivalent variations<br />

have been described ( Dorling et al. , 1981 ; Howell<br />

et al. , 1981 ). <strong>Clinical</strong> signs in Brahman calves become evident<br />

at 2 to 3 months <strong>of</strong> age with a loss <strong>of</strong> condition, poor<br />

growth, and lethargy followed by incoordination and muscle<br />

tremors with death by 9 months <strong>of</strong> age. Although the onset <strong>of</strong><br />

clinical signs may also occur within the first 2 to 3 months <strong>of</strong><br />

age, some affected shorthorn calves appear clinically normal<br />

until 5 to 9 months <strong>of</strong> age when weight gains are not maintained<br />

and progressive muscular weakness develops with<br />

death by 12 to 16 months <strong>of</strong> age. Excessive accumulation <strong>of</strong><br />

glycogen occurs in skeletal and cardiac muscle, brain, and<br />

spinal cord ( Howell et al. , 1981 ). The disorder in cattle is<br />

also inherited as an autosomal recessive trait. Two mutations<br />

have been identified in Brahmans, and one in shorthorns,<br />

that lead to generalized glycogenosis. All three mutations<br />

result in premature termination <strong>of</strong> translation ( Dennis et al. ,<br />

2000 ). In other species, single cases <strong>of</strong> generalized glycogenoses<br />

in which α -glucosidase deficiency was demonstrated<br />

include the Lapland dog ( Walvoort et al. , 1982 ) and<br />

Japanese quail ( Murakami et al. , 1980 ).<br />

2 . Debranching Enzyme Defi ciency (GSD III)<br />

Debranching enzyme possesses two activities, α-l,4glucan<br />

transferase and α -l,6-glucosidase. In the hydrolysis <strong>of</strong> glycogen,<br />

myophosphorylase acts on the α -l,4 linkages <strong>of</strong> the<br />

terminal glucose residues up to the last four glucose residues<br />

preceding the α -1,4 linkages. The α-l,4-glucan transferase<br />

transfers the last three residues to another branch and<br />

the α -1,6-glucosidase hydrolyses the α -l,6 branch point.<br />

Several presumed cases <strong>of</strong> debranching enzyme deficiency<br />

have been described in the dog ( Ceh et al. , 1976 ; Otani and<br />

Mochizuki, 1977 ; Rafiquzzaman et al. , 1976 ). Biochemical<br />

demonstration <strong>of</strong> debranching enzyme deficiency is limited<br />

to a single case ( Ceh et al. , 1976 ). There is diffuse organ<br />

involvement with glycogen storage. Onset <strong>of</strong> signs appears

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!